Boro Dropulic
50Patents
6h-index
23Co-inventors
72Inventor score
Filing activity: Nov 27, 1996 → Jan 10, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6627442B1 | Methods for stable transduction of cells with hiv-derived viral vectors | Chemistry; Metallurgy | 32 | Expired |
| US5888767A | Method of using a conditionally replicating viral vector to express a gene | Chemistry; Metallurgy | 13 | Expired |
| US10442867B2 | Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy | Chemistry; Metallurgy | 6 | Active |
| US10689431B2 | Compositions and methods for treating cancer with DuoCARs | Chemistry; Metallurgy | 6 | Active |
| US10639329B2 | Method to treat cancer with engineered T-cells | Chemistry; Metallurgy | 6 | Active |
| US5885806A | Methods to prepare conditionally replicating viral vectors | Chemistry; Metallurgy | 6 | Expired |
| US6498033B1 | Lentiviral vectors | Chemistry; Metallurgy | 5 | Expired |
| US10183993B2 | Compositions and methods for treating cancer with anti-mesothelin immunotherapy | Chemistry; Metallurgy | 5 | Active |
| US6168953A | Genetic antiviral agents and methods for their use | Chemistry; Metallurgy | 4 | Expired |
| US11242389B2 | Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy | Chemistry; Metallurgy | 4 | Active |
| US6232120A | Methods to inhibit replication of infective virus | Chemistry; Metallurgy | 4 | Expired |
| US10550179B2 | Compositions and methods for treating cancer with anti-mesothelin immunotherapy | Chemistry; Metallurgy | 4 | Active |
| US10844128B2 | Compositions and methods for treating cancer with anti-CD123 immunotherapy | Chemistry; Metallurgy | 3 | Active |
| US10822412B2 | Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy | Chemistry; Metallurgy | 3 | Active |
| US10426797B2 | Compositions and methods for treating cancer with anti-CD33 immunotherapy | Chemistry; Metallurgy | 3 | Active |
| US10501539B2 | Compositions and methods for treating cancer with anti-CD19 immunotherapy | Chemistry; Metallurgy | 3 | Active |
| US11208455B2 | Compositions and methods for treating cancer with DuoCARs | Chemistry; Metallurgy | 3 | Active |
| US6114141A | Methods to express genes from viral vectors | Chemistry; Metallurgy | 3 | Expired |
| US10421810B2 | Chimeric antigen receptors and methods of use | Chemistry; Metallurgy | 2 | Active |
| US11103533B2 | Compositions and methods for treating cancer with anti-CD38 immunotherapy | Chemistry; Metallurgy | 2 | Active |
| US6207426A | Conditionally replicating viral vectors and their use | Chemistry; Metallurgy | 2 | Expired |
| US10428141B2 | Compositions and methods for treating cancer with anti-ROR1 immunotherapy | Chemistry; Metallurgy | 2 | Active |
| US6410257B1 | Methods to assay gene function with viral vectors | Chemistry; Metallurgy | 2 | Expired |
| US10543263B2 | Compositions and methods for treating cancer with anti-CD22 immunotherapy | Chemistry; Metallurgy | 2 | Active |
| US10894819B2 | Compositions and methods for treating HIV/AIDS with immunotherapy | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.